Liftstream is an executive search recruitment company in the life sciences sector
Prosensa & GSK pool resources to drive Drisapersen in Duchenne
Authored by Karl Simpson
Posted in Orphan Drugs and Rare Diseases
Tagged Abingworth, David Mott, DMD, Drisapersen, Duchenne, Dystrophin, Exon 51, Genzyme, GSK, GSK’s Centre of Excellence for External Drug Discovery, Hans Schikan, Henri Termeer, Huntington's, Leiden University Medical Center, Massachusetts, MedImmune, mRNA, New Enterprise Associates (NEA), Phase II, PRO051, Prosensa, The New England Journal of Medicine
Leave a comment